Skip to main content
SpringerLink
Log in

First-line rituximab good value for NHL in the UK

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

First-line rituximab good value for NHL in the UK. Inpharma Wkly. 1572, 4 (2007). https://doi.org/10.2165/00128413-200715720-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200715720-00007

Keywords

Search

Navigation